Paper17567829
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.
Vallet-Pichard A and 7 others. Hepatology, 2007. Cited by 1,762 papers, by iCite.
Cite this record
ConductScience Library. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Papers, record 17567829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17567829
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers | Major topic |
| Hepatitis C | Major topic |
| Adult | |
| Alanine Transaminase | |
| Aspartate Aminotransferases | |
| Humans | |
| Liver Cirrhosis | |
| Liver Function Tests | |
| Middle Aged | |
| Patient Selection | |
| Platelet Count | |
| Predictive Value of Tests | |
| RNA, Viral | |
| Reference Values | |
| Reproducibility of Results | |
| Viral Load |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT03641872 | A Validation Cohort for ACLF Diagnosis and Prognosis | Background | ClinicalTrials.gov | |
| NCT04162938 | Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 18220307 | The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases. | https://conductscience.org/library/papers/18220307 |
Source PubMed
Cited by1,064
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,762 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947406 | Predicting Liver Stiffness Approximately 12 Months Ahead Using Serial Transient Elastography. | Can J Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42947406 | PubMed |
| 42888835 | Metabolic Dysfunction-Associated Fatty Liver Disease-Cardiovascular-Kidney-Metabolic (MAFLD-CKM): A Modified Framework to Predict Long-Term Mortality. | Med Sci Monit | 2026 | https://conductscience.org/library/papers/42888835 | PubMed |
| 42877484 | The association of cardiovascular disease (CVD) with progression of advanced fibrosis risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). | Livers | 2026 | https://conductscience.org/library/papers/42877484 | PubMed |
| 42853889 | Evaluating periportal fibrosis in schistosomiasis mansoni using the ELF [Enhanced Liver Fibrosis] score: A pilot study. | PLoS Negl Trop Dis | 2026 | https://conductscience.org/library/papers/42853889 | PubMed |
| 42848747 | Association of 5-hydroxytryptamine 3 receptor antagonists with prognosis in patients with advanced hepatocellular carcinoma: A propensity score-matched study. | PLoS One | 2026 | https://conductscience.org/library/papers/42848747 | PubMed |
| 42815963 | Discrepancy between self-perceived dietary habits and objective clinical risk of liver fibrosis: A cross-sectional study of Japanese health checkup participants. | Asia Pac J Clin Nutr | 2026 | https://conductscience.org/library/papers/42815963 | PubMed |
| 42772677 | Association between statins and chronic liver disease progression: A retrospective cohort study. | Clin Res Hepatol Gastroenterol | 2026 | https://conductscience.org/library/papers/42772677 | PubMed |
| 42769695 | Use of Noninvasive Biomarker Tests vs. FibroScan for Predicting Significant Fibrosis in Egyptian Pediatric Cancer Survivors with Chronic Hepatitis C Virus Infection. | Pediatr Gastroenterol Hepatol Nutr | 2026 | https://conductscience.org/library/papers/42769695 | PubMed |
| 42768894 | Discovery of Epidermal Growth Factor-Like 7 as a Potential Non-Invasive Biomarker for Fibrosis and Mortality Risk in MASLD. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/42768894 | PubMed |
| 42725053 | CATS-BIT-ME Score: A Machine Learning and Conventional Risk Model for Prognosis in Hepatocellular Carcinoma. | Gastro Hep Adv | 2026 | https://conductscience.org/library/papers/42725053 | PubMed |
| 42724880 | Are there any non-invasive methods to predict liver fibrosis in children infected by hepatitis C virus rather than liver biopsy? | Clin Exp Hepatol | 2026 | https://conductscience.org/library/papers/42724880 | PubMed |
| 42692359 | Interleukin13 Ameliorates Hepatocellular Steatosis via IL13Rα1/JNK/FOSL2 Signaling Pathway. | Cell Mol Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42692359 | PubMed |
| 42572772 | Association of Serum Chitinase-3-Like Protein 1 with Liver Fibrosis Severity in Autoimmune Liver Diseases. | Int J Gen Med | 2026 | https://conductscience.org/library/papers/42572772 | PubMed |
| 42571357 | Association Between Non-alcoholic Fatty Liver Disease and Subclinical Atherosclerosis Assessed by Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis. | Cureus | 2026 | https://conductscience.org/library/papers/42571357 | PubMed |
| 42515625 | Serum Gremlin 1 Remains Elevated Following Successful Direct-Acting Antiviral Therapy for Chronic Hepatitis C. | Viruses | 2026 | https://conductscience.org/library/papers/42515625 | PubMed |
| 42509734 | Dissociation of the Hepatic and Pulmonary Axes in Alpha-1 Antitrypsin Deficiency: Independent Trajectories of Organ-Specific Disease. | Biomolecules | 2026 | https://conductscience.org/library/papers/42509734 | PubMed |
| 42504271 | Development and prospective validation of a machine learning model for risk stratification of drug-induced liver injury using real-world clinical data. | Ther Adv Drug Saf | 2026 | https://conductscience.org/library/papers/42504271 | PubMed |
| 42423792 | Superior accuracy of a novel multidimensional index integrating static and dynamic liver stiffness for hepatocellular carcinoma risk prediction in chronic hepatitis B. | J Med Ultrason (2001) | 2026 | https://conductscience.org/library/papers/42423792 | PubMed |
| 42422625 | Diagnostic Performance of Non-invasive Tests for Hepatic Fibrosis Using Liver Biopsy As the Reference Standard: A Systematic Review and Meta-Analysis. | Cureus | 2026 | https://conductscience.org/library/papers/42422625 | PubMed |
| 42416572 | Metabolic Dysfunction-Associated Steatotic Liver Disease as a Systemic Driver of Heart Failure With Preserved Ejection Fraction: Mechanistic Insights and Emerging Therapeutic Perspectives. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42416572 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17567829
GET https://conductscience.org/api/papers/v1/17567829/cited_by?page=2